Luis Edgardo Ferrufino, MD | |
833 W Dove Ave, Mcallen, TX 78504 | |
(956) 618-3979 | |
(956) 618-3975 |
Full Name | Luis Edgardo Ferrufino |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 22 Years |
Location | 833 W Dove Ave, Mcallen, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1720230725 | NPI | - | NPPES |
295451301 | Medicaid | TX | |
8DE594 | Other | TX | BCBS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | MD2011-0625 (New Mexico) | Secondary |
207Q00000X | Family Medicine | P1996 (Texas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
South Texas Health System | Edinburg, TX | Hospital |
Mission Regional Medical Center | Mission, TX | Hospital |
Rio Grande Regional Hospital | Mcallen, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Planet Med Lp | 7810926227 | 4 |
News Archive
Pre-existing asthma may be a strong predictor of future chronic migraine attacks in individuals experiencing occasional migraine headaches, according to researchers from the University of Cincinnati, Montefiore Headache Center and Albert Einstein College of Medicine, and Vedanta Research.
Patients who were asked where they wanted to die upon entering hospice had lower rates of hospitalization at the end of life, as did those in hospices that monitored symptoms more frequently, according to a new study led by researchers at the Icahn School of Medicine at Mount Sinai.
Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that its affiliate VGX International Inc. has received approval in Korea to begin a Phase I clinical trial in healthy volunteers for Inovio's SynCon™ preventive DNA vaccine (VGX-3400) targeting H5N1 avian influenza.
The malignant transformation of hepatocytes is the origin of most hepatocellular carcinomas, an aggressive type of liver cancer with high mortality rates. But these cells do not act alone.
› Verified 4 days ago
Entity Name | Planet Med Lp |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1811969819 PECOS PAC ID: 7810926227 Enrollment ID: O20050805000637 |
News Archive
Pre-existing asthma may be a strong predictor of future chronic migraine attacks in individuals experiencing occasional migraine headaches, according to researchers from the University of Cincinnati, Montefiore Headache Center and Albert Einstein College of Medicine, and Vedanta Research.
Patients who were asked where they wanted to die upon entering hospice had lower rates of hospitalization at the end of life, as did those in hospices that monitored symptoms more frequently, according to a new study led by researchers at the Icahn School of Medicine at Mount Sinai.
Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that its affiliate VGX International Inc. has received approval in Korea to begin a Phase I clinical trial in healthy volunteers for Inovio's SynCon™ preventive DNA vaccine (VGX-3400) targeting H5N1 avian influenza.
The malignant transformation of hepatocytes is the origin of most hepatocellular carcinomas, an aggressive type of liver cancer with high mortality rates. But these cells do not act alone.
› Verified 4 days ago
Entity Name | Hni Medical Services |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1366735169 PECOS PAC ID: 6406028810 Enrollment ID: O20111031000750 |
News Archive
Pre-existing asthma may be a strong predictor of future chronic migraine attacks in individuals experiencing occasional migraine headaches, according to researchers from the University of Cincinnati, Montefiore Headache Center and Albert Einstein College of Medicine, and Vedanta Research.
Patients who were asked where they wanted to die upon entering hospice had lower rates of hospitalization at the end of life, as did those in hospices that monitored symptoms more frequently, according to a new study led by researchers at the Icahn School of Medicine at Mount Sinai.
Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that its affiliate VGX International Inc. has received approval in Korea to begin a Phase I clinical trial in healthy volunteers for Inovio's SynCon™ preventive DNA vaccine (VGX-3400) targeting H5N1 avian influenza.
The malignant transformation of hepatocytes is the origin of most hepatocellular carcinomas, an aggressive type of liver cancer with high mortality rates. But these cells do not act alone.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Luis Edgardo Ferrufino, MD Po Box 3238, Mission, TX 78573-0055 Ph: (956) 618-3979 | Luis Edgardo Ferrufino, MD 833 W Dove Ave, Mcallen, TX 78504 Ph: (956) 618-3979 |
News Archive
Pre-existing asthma may be a strong predictor of future chronic migraine attacks in individuals experiencing occasional migraine headaches, according to researchers from the University of Cincinnati, Montefiore Headache Center and Albert Einstein College of Medicine, and Vedanta Research.
Patients who were asked where they wanted to die upon entering hospice had lower rates of hospitalization at the end of life, as did those in hospices that monitored symptoms more frequently, according to a new study led by researchers at the Icahn School of Medicine at Mount Sinai.
Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that its affiliate VGX International Inc. has received approval in Korea to begin a Phase I clinical trial in healthy volunteers for Inovio's SynCon™ preventive DNA vaccine (VGX-3400) targeting H5N1 avian influenza.
The malignant transformation of hepatocytes is the origin of most hepatocellular carcinomas, an aggressive type of liver cancer with high mortality rates. But these cells do not act alone.
› Verified 4 days ago
Enrique Carrasco Rojas, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 501 N Ware Rd, Mcallen, TX 78501 Phone: 956-668-0044 Fax: 956-687-9747 | |
Dr. Leonel G Moreno, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 606 S Broadway Avenue, Mcallen, TX 78501 Phone: 956-682-4515 Fax: 956-662-7628 | |
Maria De Jesus Munoz, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 E Dove Ave, Mcallen, TX 78504 Phone: 956-362-3520 Fax: 956-362-3529 | |
Jesus A Zavaleta Jr., MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 204 Nolana, Mcallen, TX 78504 Phone: 956-687-9554 | |
Ricardo Canales, MD PA Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 240 Lindberg Ave, Mcallen, TX 78501 Phone: 956-686-2020 Fax: 956-686-3094 | |
Andrew Dela Garza, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 205 E Toronto Ave, Mcallen, TX 78503 Phone: 956-687-6155 | |
John Steven Hanley, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 110 E Savannah Ave Bldg A203, Mcallen, TX 78503 Phone: 956-686-4040 Fax: 956-686-2939 |